STOCK TITAN

Enovis (ENOV) grants 14,925 RSUs to its principal accounting officer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enovis Corp’s principal accounting officer John Kleckner received an equity grant of 14,925 shares of common stock on March 9, 2026. The shares were awarded at no cost as restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

On March 7, 2026, 586 shares were withheld at $24.51 per share to cover tax obligations tied to a restricted stock unit net settlement, which the company notes is not a sale by Kleckner. Following these transactions, he directly holds 25,884 common shares.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU grant with standard tax withholding, not open-market trading.

The principal accounting officer of Enovis, John Kleckner, received 14,925 restricted stock units of common stock at a grant price of $0.00. The award vests in three equal installments starting one year after the grant date, reinforcing long-term alignment between compensation and company performance.

A separate entry shows 586 shares withheld at $24.51 per share to satisfy tax obligations from a restricted stock unit net settlement. The footnote clarifies this is not a sale, so there is no open-market selling signal. After these entries, Kleckner holds 25,884 common shares directly, indicating a continuing equity stake.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KLECKNER JOHN

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Principal Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 03/07/2026 F 586(1) D $24.51 10,959 D
Common stock, par value $0.001 03/09/2026 A 14,925(2) A $0.00 25,884 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the reporting person.
2. This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Brian P. Hanigan, attorney-in-fact 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award did Enovis (ENOV) grant to John Kleckner?

Enovis granted John Kleckner 14,925 restricted stock units of common stock at a grant price of $0.00 per share. These RSUs vest in three equal annual installments, starting on the first anniversary of the grant date, encouraging long-term retention and performance alignment.

How do the 14,925 Enovis RSUs awarded to Kleckner vest over time?

The 14,925 restricted stock units awarded to Kleckner vest in three equal annual installments. Vesting begins on the first anniversary of the grant date, meaning one‑third of the units vest each year for three years, subject to the award’s standard conditions.

Did John Kleckner sell Enovis (ENOV) shares in this Form 4 filing?

No open-market sale occurred. The filing shows 586 shares were withheld by Enovis at $24.51 per share to satisfy tax withholding and remittance obligations related to restricted stock units, and the footnote explicitly states this does not represent a sale by Kleckner.

Why were 586 Enovis shares withheld from John Kleckner?

The 586 shares were withheld to cover tax withholding and remittance obligations tied to the net settlement of restricted stock units. This is a common, non-market mechanism where the company withholds shares instead of the insider paying cash for the related tax liability.

How many Enovis (ENOV) shares does John Kleckner hold after these transactions?

After the reported transactions, Kleckner directly holds 25,884 shares of Enovis common stock. This figure reflects the impact of the 14,925-share restricted stock award and the 586 shares withheld for taxes, as disclosed in the post-transaction ownership totals.

What does the Form 4 reveal about Enovis’s use of RSUs for executive pay?

The Form 4 shows Enovis using restricted stock units as a key compensation tool. Kleckner’s 14,925-unit grant, vesting over three years, ties part of his pay to future company performance, with share withholding used to handle tax obligations at vesting or settlement.
Enovis Corp

NYSE:ENOV

View ENOV Stock Overview

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.34B
55.92M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON